155 related articles for article (PubMed ID: 33390109)
1. Mesenchymal Stromal Cell-derived Exosomes Attenuate Experimental Pulmonary Arterial Hypertension.
Ge L; Jiang W; Zhang S; Wang J; Xin Q; Sun C; Li K; Qi T; Luan Y
Curr Pharm Biotechnol; 2021; 22(12):1654-1662. PubMed ID: 33390109
[TBL] [Abstract][Full Text] [Related]
2. Mesenchymal stromal cell-derived exosomes improve pulmonary hypertension through inhibition of pulmonary vascular remodeling.
Zhang S; Liu X; Ge LL; Li K; Sun Y; Wang F; Han Y; Sun C; Wang J; Jiang W; Xin Q; Xu C; Chen Y; Chen O; Zhang Z; Luan Y
Respir Res; 2020 Mar; 21(1):71. PubMed ID: 32192495
[TBL] [Abstract][Full Text] [Related]
3. Exosomes derived from mesenchymal stromal cells exert a therapeutic effect on hypoxia-induced pulmonary hypertension by modulating the YAP1/SPP1 signaling pathway.
Chen YX; Deng ZH; Xue-Gao ; Qiang-Du ; Juan-Yin ; Chen GH; Li JG; Zhao YM; Zhang HT; Zhang GX; Qian JX
Biomed Pharmacother; 2023 Dec; 168():115816. PubMed ID: 37918254
[TBL] [Abstract][Full Text] [Related]
4. Exosomes induce and reverse monocrotaline-induced pulmonary hypertension in mice.
Aliotta JM; Pereira M; Wen S; Dooner MS; Del Tatto M; Papa E; Goldberg LR; Baird GL; Ventetuolo CE; Quesenberry PJ; Klinger JR
Cardiovasc Res; 2016 Jun; 110(3):319-30. PubMed ID: 26980205
[TBL] [Abstract][Full Text] [Related]
5. The protective effects of MSC-EXO against pulmonary hypertension through regulating Wnt5a/BMP signalling pathway.
Zhang Z; Ge L; Zhang S; Wang J; Jiang W; Xin Q; Luan Y
J Cell Mol Med; 2020 Dec; 24(23):13938-13948. PubMed ID: 33090702
[TBL] [Abstract][Full Text] [Related]
6. Induced pluripotent stem cell-derived exosomes attenuate vascular remodelling in pulmonary arterial hypertension by targeting HIF-1α and Runx2.
Chi PL; Cheng CC; Wang MT; Liao JB; Kuo SH; Lin KC; Shen MC; Huang WC
Cardiovasc Res; 2024 Mar; 120(2):203-214. PubMed ID: 38252891
[TBL] [Abstract][Full Text] [Related]
7. [Effects of human umbilical cord mesenchymal stem cells (MSCs)-derived exosomes on pulmonary vascular remodeling in hypoxic pulmonary hypertension].
Liu H; Zhang YW; Zhang QQ; Wang YX; Ge RL; Ma L
Sheng Li Xue Bao; 2024 Feb; 76(1):33-44. PubMed ID: 38444129
[TBL] [Abstract][Full Text] [Related]
8. Let-7a-transfected mesenchymal stem cells ameliorate monocrotaline-induced pulmonary hypertension by suppressing pulmonary artery smooth muscle cell growth through STAT3-BMPR2 signaling.
Cheng G; Wang X; Li Y; He L
Stem Cell Res Ther; 2017 Feb; 8(1):34. PubMed ID: 28187784
[TBL] [Abstract][Full Text] [Related]
9. 3-Bromopyruvate alleviates the development of monocrotaline-induced rat pulmonary arterial hypertension by decreasing aerobic glycolysis, inducing apoptosis, and suppressing inflammation.
Liu J; Wang W; Wang L; Qi XM; Sha YH; Yang T
Chin Med J (Engl); 2020 Jan; 133(1):49-60. PubMed ID: 31923104
[TBL] [Abstract][Full Text] [Related]
10. Mesenchymal stromal cell therapy reduces lung inflammation and vascular remodeling and improves hemodynamics in experimental pulmonary arterial hypertension.
de Mendonça L; Felix NS; Blanco NG; Da Silva JS; Ferreira TP; Abreu SC; Cruz FF; Rocha N; Silva PM; Martins V; Capelozzi VL; Zapata-Sudo G; Rocco PRM; Silva PL
Stem Cell Res Ther; 2017 Oct; 8(1):220. PubMed ID: 28974252
[TBL] [Abstract][Full Text] [Related]
11. Implantation of mesenchymal stem cells overexpressing endothelial nitric oxide synthase improves right ventricular impairments caused by pulmonary hypertension.
Kanki-Horimoto S; Horimoto H; Mieno S; Kishida K; Watanabe F; Furuya E; Katsumata T
Circulation; 2006 Jul; 114(1 Suppl):I181-5. PubMed ID: 16820570
[TBL] [Abstract][Full Text] [Related]
12. Pulmonary arterial hypertension induced by a novel method: Twice-intraperitoneal injection of monocrotaline.
Zhuang W; Lian G; Huang B; Du A; Xiao G; Gong J; Xu C; Wang H; Xie L
Exp Biol Med (Maywood); 2018 Aug; 243(12):995-1003. PubMed ID: 30099957
[TBL] [Abstract][Full Text] [Related]
13. Tibetan Mesenchymal Stem Cell-derived Exosomes Alleviate Pulmonary Vascular Remodeling in Hypoxic Pulmonary Hypertension Rats.
Zhang Q; Liu H; Liu C; Wang Y; Huang P; Wang X; Ma Y; Ma L; Ge R
Stem Cells; 2024 May; ():. PubMed ID: 38717187
[TBL] [Abstract][Full Text] [Related]
14. Prostaglandin E1 reduces apoptosis and improves the homing of mesenchymal stem cells in pulmonary arterial hypertension by regulating hypoxia-inducible factor 1 alpha.
Jiang DT; Tuo L; Bai X; Bing WD; Qu QX; Zhao X; Song GM; Bi YW; Sun WY
Stem Cell Res Ther; 2022 Jul; 13(1):316. PubMed ID: 35842683
[TBL] [Abstract][Full Text] [Related]
15. Bone Marrow Endothelial Progenitor Cells Are the Cellular Mediators of Pulmonary Hypertension in the Murine Monocrotaline Injury Model.
Aliotta JM; Pereira M; Wen S; Dooner MS; Del Tatto M; Papa E; Cheng Y; Goldberg L; Ventetuolo CE; Liang O; Klinger JR; Quesenberry PJ
Stem Cells Transl Med; 2017 Jul; 6(7):1595-1606. PubMed ID: 28474513
[TBL] [Abstract][Full Text] [Related]
16. Allogenic stem cell therapy improves right ventricular function by improving lung pathology in rats with pulmonary hypertension.
Umar S; de Visser YP; Steendijk P; Schutte CI; Laghmani el H; Wagenaar GT; Bax WH; Mantikou E; Pijnappels DA; Atsma DE; Schalij MJ; van der Wall EE; van der Laarse A
Am J Physiol Heart Circ Physiol; 2009 Nov; 297(5):H1606-16. PubMed ID: 19783775
[TBL] [Abstract][Full Text] [Related]
17. Activation of AMPK prevents monocrotaline-induced pulmonary arterial hypertension by suppression of NF-κB-mediated autophagy activation.
Zhai C; Shi W; Feng W; Zhu Y; Wang J; Li S; Yan X; Wang Q; Zhang Q; Chai L; Li C; Liu P; Li M
Life Sci; 2018 Sep; 208():87-95. PubMed ID: 30009823
[TBL] [Abstract][Full Text] [Related]
18. Mesenchymal stem cells attenuate vascular remodeling in monocrotaline-induced pulmonary hypertension rats.
Xie J; Hu D; Niu L; Qu S; Wang S; Liu S
J Huazhong Univ Sci Technolog Med Sci; 2012 Dec; 32(6):810-817. PubMed ID: 23271278
[TBL] [Abstract][Full Text] [Related]
19. Implantation of mesenchymal stem cells improves right ventricular impairments caused by experimental pulmonary hypertension.
Luan Y; Zhang ZH; Wei DE; Zhao JJ; Kong F; Cheng GH; Wang YB
Am J Med Sci; 2012 May; 343(5):402-6. PubMed ID: 21876426
[TBL] [Abstract][Full Text] [Related]
20. The Effect of Umbilical Cord Blood Derived Mesenchymal Stem Cells in Monocrotaline-induced Pulmonary Artery Hypertension Rats.
Lee H; Lee JC; Kwon JH; Kim KC; Cho MS; Yang YS; Oh W; Choi SJ; Seo ES; Lee SJ; Wang TJ; Hong YM
J Korean Med Sci; 2015 May; 30(5):576-85. PubMed ID: 25931788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
